nialamide has been researched along with Blepharoptosis in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Blepharoptosis: Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, T | 1 |
| Katsuyama, M | 1 |
| Karai, N | 1 |
| Hirose, A | 1 |
| Nakamura, M | 1 |
| Katsube, J | 1 |
| Taha, AM | 1 |
| Omar, NM | 1 |
| Bayomi, SM | 1 |
| Ammar, EM | 1 |
| Afifi, A | 1 |
2 other studies available for nialamide and Blepharoptosis
| Article | Year |
|---|---|
Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
Topics: Animals; Blepharoptosis; Brain Chemistry; Droxidopa; Drug Synergism; Imipramine; Injections, Intrave | 1986 |
Synthesis and screening of cyclic benzylhydrazine congeners as antidepressants.
Topics: Amphetamine; Animals; Antidepressive Agents; Benzyl Compounds; Blepharoptosis; Chemical Phenomena; C | 1974 |